Alpha 2.0
Login Register
» Authors » Neshaad Schrueder

Neshaad Schrueder

Explore the profile of Neshaad Schrueder including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 505
Followers 0
Related Specialties
Infectious Diseases
General Medicine
Cardiology & Vascular Diseases
Top 10 Co-Authors
Arifa Parker
Mary-Ann Davies
Graeme Meintjes
Sean Wasserman
Linda Boloko
Cheryl Cohen
Peter Raubenheimer
Wolfgang Preiser
Hannah Hussey
Robert J Wilkinson
Published In
medRxiv
BMC Infect Dis
Int J Infect Dis
S Afr Med J
Eur Heart J
Affiliations
Soon will be listed here.
Recent Articles
1.
Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study
Hussey H, Davies M, Heekes A, Williamson C, Valley-Omar Z, Hardie D, et al.
Gates Open Res . 2023 Nov; 6:117. PMID: 37994361
The SARS-CoV-2 Delta variant (B.1.617.2) has been associated with more severe disease, particularly when compared to the Alpha variant. Most of this data, however, is from high income countries and...
2.
The interface between SARS-CoV-2 and non-communicable diseases (NCDs) in a high HIV/TB burden district level hospital setting, Cape Town, South Africa
Mnguni A, Schietekat D, Ebrahim N, Sonday N, Boliter N, Schrueder N, et al.
PLoS One . 2023 Oct; 18(10):e0277995. PMID: 37796879
Background: COVID-19 experiences on noncommunicable diseases (NCDs) from district-level hospital settings during waves I and II are scarcely documented. The aim of this study is to investigate the NCDs associated...
3.
The clinical and epidemiological characteristics of a series of patients living with HIV admitted for COVID-19 in a district hospital
Mnguni A, Schietekat D, Ebrahim N, Sonday N, Boliter N, Schrueder N, et al.
BMC Infect Dis . 2023 Mar; 23(1):123. PMID: 36855103
Background: The coronavirus disease 2019 (COVID-19) pandemic continues to evolve. Globally, COVID-19 continues to strain even the most resilient healthcare systems, with Omicron being the latest variant. We made a...
4.
A tale of two waves: characteristics and outcomes of COVID-19 admissions during the Omicron-driven fourth wave in Cape Town, South Africa, and implications for the future
Moolla M, Maponga T, Moolla H, Kollenberg E, Anie S, Moolla A, et al.
IJID Reg . 2022 Nov; 6:42-47. PMID: 36448029
Objectives: The aim of this study was to describe the pattern of admissions during the fourth wave of COVID-19 in order to inform future public health policies. Methods: This was...
5.
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa
Davies M, Morden E, Rousseau P, Arendse J, Bam J, Boloko L, et al.
Int J Infect Dis . 2022 Nov; 127:63-68. PMID: 36436752
Objectives: We aimed to compare the clinical severity of Omicron BA.4/BA.5 infection with BA.1 and earlier variant infections among laboratory-confirmed SARS-CoV-2 cases in the Western Cape, South Africa, using timing...
6.
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa
Davies M, Morden E, Rosseau P, Arendse J, Bam J, Boloko L, et al.
medRxiv . 2022 Jul; PMID: 35794899
Objective: We aimed to compare clinical severity of Omicron BA.4/BA.5 infection with BA.1 and earlier variant infections among laboratory-confirmed SARS-CoV-2 cases in the Western Cape, South Africa, using timing of...
7.
Clinical features and outcomes of COVID-19 admissions in a population with a high prevalence of HIV and tuberculosis: a multicentre cohort study
Parker A, Boloko L, Moolla M, Ebrahim N, Ayele B, Broadhurst A, et al.
BMC Infect Dis . 2022 Jun; 22(1):559. PMID: 35725387
Background: There is still a paucity of evidence on the outcomes of coronavirus disease 2019 (COVID-19) among people living with human immunodeficiency virus (PWH) and those co-infected with tuberculosis (TB),...
8.
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa
Davies M, Kassanjee R, Rousseau P, Morden E, Johnson L, Solomon W, et al.
Trop Med Int Health . 2022 Apr; 27(6):564-573. PMID: 35411997
Objectives: The objective was to compare COVID-19 outcomes in the Omicron-driven fourth wave with prior waves in the Western Cape, assess the contribution of undiagnosed prior infection to differences in...
9.
Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections - a survival analysis
Hussey H, Davies M, Heekes A, Williamson C, Valley-Omar Z, Hardie D, et al.
Int J Infect Dis . 2022 Mar; 118:150-154. PMID: 35235826
Background: At present, it is unclear whether the extent of reduced risk of severe disease seen with SARS-Cov-2 Omicron variant infection is caused by a decrease in variant virulence or...
10.
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa
Davies M, Kassanjee R, Rosseau P, Morden E, Johnson L, Solomon W, et al.
medRxiv . 2022 Jan; PMID: 35043121
Objectives: We aimed to compare COVID-19 outcomes in the Omicron-driven fourth wave with prior waves in the Western Cape, the contribution of undiagnosed prior infection to differences in outcomes in...